Hillman Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Sell |
41,972
-2,053
| -5% | -$258K | 2.88% | 17 |
|
|
2025
Q1 | $6.02M | Buy |
44,025
+959
| +2% | +$131K | 2.96% | 18 |
|
|
2024
Q4 | $6.59M | Buy |
43,066
+7,813
| +22% | +$1.19M | 2.44% | 19 |
|
|
2024
Q3 | $6.83M | Sell |
35,253
-701
| -2% | -$136K | 2.34% | 22 |
|
|
2024
Q2 | $8.33M | Buy |
35,954
+162
| +0.5% | +$37.6K | 2.94% | 10 |
|
|
2024
Q1 | $7.72M | Buy |
35,792
+1,316
| +4% | +$284K | 2.48% | 23 |
|
|
2023
Q4 | $8.92M | Buy |
34,476
+170
| +0.5% | +$44K | 3.08% | 10 |
|
|
2023
Q3 | $8.82M | Buy |
34,306
+4,895
| +17% | +$1.26M | 3.39% | 2 |
|
|
2023
Q2 | $8.38M | Sell |
29,411
-125
| -0.4% | -$35.6K | 2.96% | 12 |
|
|
2023
Q1 | $8.21M | Sell |
29,536
-540
| -2% | -$150K | 3.11% | 15 |
|
|
2022
Q4 | $8.33M | Sell |
30,076
-1,678
| -5% | -$465K | 3.27% | 10 |
|
|
2022
Q3 | $8.48M | Sell |
31,754
-11,265
| -26% | -$3.01M | 3.52% | 4 |
|
|
2022
Q2 | $8.77M | Buy |
43,019
+340
| +0.8% | +$69.3K | 3.19% | 10 |
|
|
2022
Q1 | $8.99M | Buy |
42,679
+15,488
| +57% | +$3.26M | 2.85% | 16 |
|
|
2021
Q4 | $6.52M | Sell |
27,191
-1,098
| -4% | -$263K | 2.24% | 30 |
|
|
2021
Q3 | $8.01M | Buy |
28,289
+1,050
| +4% | +$297K | 2.81% | 21 |
|
|
2021
Q2 | $9.43M | Sell |
27,239
-50
| -0.2% | -$17.3K | 3.59% | 6 |
|
|
2021
Q1 | $7.63M | Buy |
27,289
+7,360
| +37% | +$2.06M | 3.35% | 14 |
|
|
2020
Q4 | $4.88M | Buy |
19,929
+292
| +1% | +$71.5K | 2.63% | 21 |
|
|
2020
Q3 | $5.57M | Buy |
19,637
+3,391
| +21% | +$962K | 3.92% | 4 |
|
|
2020
Q2 | $4.35M | Sell |
16,246
-134
| -0.8% | -$35.9K | 3.17% | 14 |
|
|
2020
Q1 | $5.18M | Sell |
16,380
-1,734
| -10% | -$549K | 4.96% | 2 |
|
|
2019
Q4 | $5.38M | Buy |
+18,114
| New | +$5.38M | 3.81% | 4 |
|